Ruth Ladenstein

Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients

Michael Paulussen, Alan Craft, Ian Lewis et al. · Journal of Clinical Oncology · 2008 · 258 citations · Full text

Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)

K. Winkler, Stefan Bielack, G. Delling et al. · Cancer · 1990 · 148 citations

Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma

Tobias M. Dantonello, Christoph Int‐Veen, Andreas Schuck et al. · Pediatric Blood & Cancer · 2013 · 57 citations

Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma

Tobias M. Dantonello, Monika Stark, Beate Timmermann et al. · Pediatric Blood & Cancer · 2014 · 37 citations

The prognostic impact of SYT‐SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials

Sabine Stegmaier, Ivo Leuschner, Christopher Poremba et al. · Pediatric Blood & Cancer · 2016 · 36 citations